Adine, Christabella, Fernando, Kanishka, Ho, Nicholas Ching Wei, Quah, Hong Sheng, Ho, Samantha Shu Wen, Wu, Kenny Zhuoran, Teng, Karen Wei Weng, Arcinas, Camille, Li, Ling, Ha, Kelly, Chew, Joey Wei Ling, Wang, Chenhui, Too, Nathaniel Sheng Hua, Yeong, Joe Poh Sheng, Tan, Daniel Shao Weng, Tan, Iain Bee Huat, Nagadia, Rahul, Chia, Claramae Shulyn, Macalinao, Dominique, and Bhuvaneswari, Hariraman
Ex vivo patient-derived tumor slices (PDTS) are currently limited by short-term viability in culture. Here, we show how bioengineered hydrogels enable the identification of key matrix parameters that significantly enhance PDTS viability compared to conventional culture systems. As demonstrated using single-cell RNA sequencing and high-dimensional flow cytometry, hydrogel-embedded PDTS tightly preserved cancer, cancer-associated fibroblast, and various immune cell populations and subpopulations in the corresponding original tumor. Cell-cell communication networks within the tumor microenvironment, including immune checkpoint ligand-receptor interactions, were also maintained. Remarkably, our results from a co-clinical trial suggest hydrogel-embedded PDTS may predict sensitivity to immune checkpoint inhibitors (ICIs) in head and neck cancer patients. Further, we show how these longer term-cultured tumor explants uniquely enable the sampling and detection of temporal evolution in molecular readouts when treated with ICIs. By preserving the compositional heterogeneity and complexity of patient tumors, hydrogel-embedded PDTS provide a valuable tool to facilitate experiments targeting the tumor microenvironment. [ABSTRACT FROM AUTHOR]